Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 19;7(4):337-348.
doi: 10.1016/j.mayocpiqo.2023.05.002. Online ahead of print.

Psychophysiologic Symptom Relief Therapy (PSRT) for Post-acute Sequelae of COVID-19

Affiliations

Psychophysiologic Symptom Relief Therapy (PSRT) for Post-acute Sequelae of COVID-19

Michael Donnino et al. Mayo Clin Proc Innov Qual Outcomes. .

Abstract

Objective: To determine if psychophysiologic symptom relief therapy (PSRT) will reduce symptom burden in patients suffering from post-acute sequelae of COVID-19 (PASC) who had mild/moderate acute COVID-19 disease without objective evidence of organ injury.

Patients and methods: Twenty-three adults under the age of 60 with PASC for at least 12 weeks following COVID-19 infection were enrolled in an interventional cohort study conducted via virtual platform between May 18, 2021 and August 7, 2022. Participants received PSRT during a 13 week (approximately 44 hour) course. Participants were administered validated questionnaires at baseline and at 4, 8, and 13 weeks. The primary outcome was change in somatic symptoms from baseline, measured using the Somatic Symptom Scale-8 (SSS-8), at 13 weeks.

Results: The median duration of symptoms prior to joining the study was 267 days (IQR: 144, 460). The mean SSS-8 score of the cohort decreased from baseline by 8.5 (95% CI: 5.7-11.4), 9.4 (95% CI: 6.9-11.9), and 10.9 (95% CI: 8.3-13.5) at 4, 8, and 13 weeks respectively (all p<.001). Participants also experienced statistically significant improvements across other secondary outcomes including changes in dyspnea, fatigue, and pain (all p<.001).

Conclusion: PSRT may effectively decrease symptom burden in patients suffering from PASC without evidence of organ injury. The study was registered on clinicaltrials.gov (NCT04854772).

PubMed Disclaimer

Conflict of interest statement

This work has been supported by Adam D’Angelo and Jim O’Shaughnessy. The authors report no competing interests.

Figures

Figure 1
Figure 1
Participant flow through the study.
Figure 2
Figure 2
Percent of participants with high/very high SSS-8 symptoms. Scoring of the SSS-8 is categorized as follows: no to minimal (0-3 points), low (4-7 points), medium (8-11 points), high (12-15 points), and very high (16-32 points) somatic symptom burden. SSS-8, Somatic Symptom Scale-8.

References

    1. World Health Organization Post COVID-19 condition. https://www.who.int/teams/health-care-readiness/post-covid-19-condition
    1. van Kessel S.A.M., Olde Hartman T.C., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159–167. doi: 10.1093/fampra/cmab076. - DOI - PMC - PubMed
    1. Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M., Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452–461. doi: 10.1016/S0140-6736(22)01214-4. - DOI - PMC - PubMed
    1. World Health Organization Post COVID-19 condition. https://www.who.int/srilanka/news/detail/16-10-2021-post-covid-19-condition
    1. Brookings New data shows long COVID is keeping as many as 4 million people out of work. https://www.brookings.edu/research/new-data-shows-long-covid-is-keeping-...

Associated data